XNYS · Healthcare · Healthcare Plans
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
Elevance delivered a strong quarter in managed care, beating EPS by **$1.25** and revenue by **$1.2B** as margin improved to **2.8%**. Management reaffirmed 2026 adjusted earnings of at least **$26.75**, reinforcing steady execution despite a heavy unfavorable-item burden.
AI-generated summary — powered by BigEarnings.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-15 | Q2 2026 | 6.20 | 7.45 | +20.16% | $49.83B | ✅ Beat | +0.07% | — | — |
| 2026-04-22 | Q1 2026 | 10.74 | 12.58 | +17.13% | $49.49B | ✅ Beat | +1.40% | +14.76% | +20.26% |
| 2026-01-28 |
| Q4 2025 |
| 3.10 |
| 3.33 |
| +7.42% |
| $49.31B |
| ✅ Beat |
| -0.29% |
| -0.37% |
| -6.39% |
| 2025-10-21 | Q3 2025 | 4.96 | 6.03 | +21.57% | $50.09B | ✅ Beat | — | — | — |
| 2025-04-22 | Q1 2025 | 11.38 | 11.97 | +5.18% | $48.77B | ✅ Beat | +2.64% | -0.54% | -7.55% |
| 2025-01-23 | Q4 2024 | 3.86 | 3.84 | -0.52% | $44.99B | ❌ Miss | -0.10% | -0.51% | -4.01% |
| 2024-10-17 | Q3 2024 | 9.66 | 8.37 | -13.35% | $44.72B | ❌ Miss | -3.06% | -5.70% | -9.82% |
| 2024-07-17 | Q2 2024 | 10.01 | 10.12 | +1.10% | $43.22B | ✅ Beat | -3.11% | -1.69% | +4.37% |
Showing last 8 quarters.